Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

MLA

Daniele Laszlo, et al. “Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.” Transplantation and Cellular Therapy, vol. 27, no. 3, Sept. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8df55b7db072d219d18f511d384768bf&authtype=sso&custid=ns315887.

APA

Daniele Laszlo, Claudia Cellini, Federica Monaco, Martina Chiarucci, Massimo Martino, Attilio Guarini, Elisabetta Fabbri, Eliana Zuffa, Beatrice Anna Zannetti, Attilio Olivieri, Francesco Lanza, Manuela Imola, Patrizia Tosi, & Francesco Saraceni. (2020). Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study. Transplantation and Cellular Therapy, 27(3).

Chicago

Daniele Laszlo, Claudia Cellini, Federica Monaco, Martina Chiarucci, Massimo Martino, Attilio Guarini, Elisabetta Fabbri, et al. 2020. “Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study.” Transplantation and Cellular Therapy 27 (3). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....8df55b7db072d219d18f511d384768bf&authtype=sso&custid=ns315887.